Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2025)

LifeStance Health (LFST) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with $11.7 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 264.06% to $11.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Dec 2025, up 116.82% year-over-year, with the annual reading at $9.7 million for FY2025, 116.82% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $11.7 million at LifeStance Health, up from $1.1 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $11.7 million in Q4 2025, with the low at -$120.5 million in Q3 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$39.7 million, with a median of -$41.4 million recorded in 2022.
  • The sharpest move saw Net Income towards Common Stockholders plummeted 3556.71% in 2021, then soared 264.06% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$108.0 million in 2021, then skyrocketed by 56.81% to -$46.7 million in 2022, then grew by 3.64% to -$45.0 million in 2023, then surged by 84.18% to -$7.1 million in 2024, then skyrocketed by 264.06% to $11.7 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $11.7 million, $1.1 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.